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Abstract
Background: The It’s LiFe! monitoring and feedback tool embedded in
primary care practice is promising in helping people to achieve an
active lifestyle. This new tool consists of an activity monitor (the
MOX), which is connected to a smartphone application and to a Web
service for patients and care providers. The aim of this study was to
develop thresholds for the moderate and vigorous activity categories and
examine the concurrent validity of the MOX in relation to the ActiGraph
(Pensacola, FL) GT3X in healthy participants and chronically ill pa-
tients (chronic obstructive pulmonary disease and type 2 diabetes) in a
laboratory situation and during daily living. Materials and Methods:
Participants wore the two activity monitors simultaneously on the lower
back. An incremental treadmill protocol was executed by 8 healthy adults
and 10 patients. For daily living measurements, 15 healthy adults and
12 patients wore the devices for 6–7 days. Daily living data were cor-
rected for non-wear time, using diary information. Results: On the
treadmill there was an excellent correlation between the ActiGraph and
MOX counts (mean r = 0.99 in healthy participants and mean r = 0.98
in patients). Correlation during daily living was moderate (mean
r = 0.72) in healthy adults and good (mean r = 0.82) in patients. Bland–
Altman plots showed no perfect agreement between the two devices in
minutes per category. However, a histogram of misclassified minutes
showed that misclassification occurred around category thresholds.
Conclusions: The MOX is capable of measuring physical activity and
can be used in the It’s LiFe! intervention.




ngagement in regular physical activity is effective in the
primary and secondary prevention of several chronic dis-
eases (e.g., cardiovascular disease, diabetes, and some can-
cers) and reduces the risk of premature death.1,2 Globally,
however, 31% of the people above 15 years old are insufficiently
active.3 Therefore numerous physical activity–promoting interven-
tions have been developed. The most successful behavioral inter-
ventions include a mix of behavior change techniques, such as goal
setting, barrier identification, action planning, social support, self-
monitoring of behavior, revising of behavioral goals, and giving
advice and providing written materials.4–6 Technology can help to
ease the implementation of behavior change techniques in daily
practice and can support healthcare professionals in their coaching
role. For example, pedometers in physical activity interventions,
when used for self-monitoring, seem to increase the daily steps sig-
nificantly, especially when combined with goal setting.7 However,
the ability of pedometers to assess free-living activity is limited be-
cause they cannot measure the frequency, duration, and intensity of
physical activity.8 Accelerometers do have these possibilities.
In the newly developed It’s LiFe! intervention,9–12 a monitoring
and feedback tool embedded in a behavior change counseling pro-
tocol supports patients in achieving an active lifestyle and gives care
providers the possibility of using objective activity results while
coaching. The purpose of the intervention is to support participants
to increase the time spent in the moderate and vigorous activity
category and diminish the time spent in the sedentary category. The
It’s LiFe! tool (Fig. 1) consists of an accelerometer (MOX), which is
connected to a smartphone with Bluetooth (Bluetooth SIG, Kirk-
land, WA). On both the smartphone and on a Web site users can see
their minutes of activity in the moderate and vigorous category
compared with their personal goal in minutes per day and receive
feedback messages and behavioral change dialogue sessions. All
feedback messages are in a positive tone and are based on personal
goal achievement. Dialogue sessions make participants aware of the
physical activities they prefer and barriers to overcome and guide
them in activity planning and searching for social support. What
makes the It’s LiFe! tool unique is that it is developed in a user-
centered design process together with patients and care providers9
and that the activity results and answers to dialogue sessions are
automatically sent to the care provider. The care provider uses the
information to set an appropriate activity goal together with the
patient, which reinforces awareness, motivation, and support for
the behavior change. Currently this coaching role is executed by a
practice nurse in primary care.
To make use of the full potential of the user-centered design ap-
proach, it was necessary that all features of the tool were adaptable.
Therefore a new activity monitor (the MOX) was developed that al-
lowed adaptation of the algorithm to the preferences of the end users
and that could communicate with other systems.




















































For an effective intervention with sufficient adherence from users,
it is necessary that the tool provides accurate activity results.
Methods to validate accelerometers include the following: against
doubly labeled water (DLW),8 (video) observation, indirect calori-
metry, or another accurate accelerometer. DLW is expensive and
merely gives information about energy expenditure rather than the
distribution of activity bouts over time, and indirect calorimetry and
video observation are only suitable in a laboratory setting. Therefore,
we chose to evaluate the MOX in relation to another accelerometer,
the ActiGraph (Pensacola, FL) GT3X. The ActiGraph GT3X is one of
the most widely used and validated activity monitors in researcher
environments13–15 and correlates as one of the best with indirect
calorimetry (r = 0.77)16 and DLW (r = 0.68).17
The goal of the current study was twofold. First, thresholds for
different activity intensities for the MOX were determined. Second,
the It’s LiFe! activity monitor, the MOX, was validated against the
ActiGraph GT3X. This was tested on a treadmill and in daily life. This
research was conducted in both healthy adults and in different pa-
tient populations because activity monitor output can differ between
populations, owing to a difference in walking patterns.18
Materials and Methods
STUDY DESIGN
The following methods were used for the multiple purposes of this
study.
Thresholds of the MOX were defined for different intensity levels
(moderate and vigorous) by analyzing the data of five healthy par-
ticipants who wore the MOX and the ActiGraph simultaneously
during daily living. Thresholds for these categories were defined
because feedback of the tool is aimed at these categories.
The concurrent validity of the two monitors was defined, and the
thresholds of the MOX were validated by the data of an incremental
treadmill protocol by 8 healthy adults and 10 participants with
chronic obstructive pulmonary disease (COPD) or type 2 diabetes and
data of a second group of 10 healthy participants and 12 people with
COPD or type 2 diabetes during daily living.
PARTICIPANTS
Twenty-two healthy volunteers (18–70 years of age) were re-
cruited from the researchers’ local networks by an invitation letter.
Thirteen volunteers with COPD or type 2 diabetes (40 years or older),
who were able to walk independently, were recruited by patient
representatives from the national patient associations and by a
practice nurse through an invitation letter. One healthy participant
and 9 patients contributed to both the measurements on the treadmill
and during daily living. Written informed consent was obtained from
all participants before study initiation. Confidential processing of data
and anonymity were guaranteed. Participants had the opportunity to
withdraw from the study at any time. The Medical Ethical Committee of
MUMC + approved this study (protocol number 11-4-120).
ACTIVITY MONITORS
The MOX (model MMOXX1.01) is an activity monitor (4.5 ·
4.0 · 1.4 cm) with a sample frequency of 25Hz. The MOX measures, in
three axes, the acceleration data ( – 6 G). The data are filtered with a
Butterworth 0.1-Hz 4th-order high-pass filter. These data are con-
verted to activity counts via embedded software by integrating the
acceleration over 1-min episodes and summing this outcome for all
three axes. Subsequently the data are calibrated so that a constant
acceleration of 1 G over 1 min corresponds to 1,000 counts.19 The
ActiGraph GT3X is a three-axis activity monitor (3.8 · 3.7 · 1.8 cm)
with a sample frequency of 30 Hz, which provides activity data in a
scale from 0 to 15,000 counts/min. In both devices the counts were
recorded in the internal memory housed in the monitor and transferred
to a computer with a micro-USB. For the ActiGraph, the program
ActiLife version 5.10.0 was used, whereas for the MOX, MOXBW0
software was used. In the It’s LiFe! intervention the MOX will transfer
its data automatically with Bluetooth to a smartphone.
DATA COLLECTION PROCEDURES
Throughout testing, the two activity monitors were worn simul-
taneously next to each other with an elastic belt tightly secured at the
lower back. The devices were synchronized with the time on the same
computer, and batteries were charged by the researchers before dis-
tribution, as the devices were able to monitor for 8 days. People with
type 2 diabetes were asked to report their last measured glycosylated
hemoglobin value, and people with COPD were asked to report their
last spirometry results.
Treadmill. All participants wore normal clothes (with a restriction
of high heels) with the MOX and the ActiGraph on their lower back.
Fig. 1. The It’s LiFe! monitoring and feedback tool. The MOX
and the real-time feedback (activity results in minutes a day
compared with a personal goal) on the smartphone application
are shown.
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For the healthy participants, the treadmill started at 3 km/h (1.9 mph)
and became faster every minute by 1 km/h (0.6 mph) until the par-
ticipant indicated he or she wanted to stop. Maximum speed was
11 km/h (6.8 mph). The participants with a chronic disease started at a
pace of 2 km/h (1.2 mph). The treadmill speed was increased every
3 min by 0.5 km/h (0.3 mph) until the patients indicated they wanted
to stop, to prevent overexertion.
Monitoring of activities during daily living. The activity pattern
during daily life was measured for 6–7 consecutive days during waking
hours, except for showering, swimming, or other water activities. The
participants were asked to undertake their normal daily activities and
to keep a diary to report at what time they wore the devices.
STATISTICAL ANALYSIS
All analyses were performed using IBM (Armonk, NY) Statistical
Product and Service Solutions (SPSS version 20.0). Graphs were
conducted in Microsoft (Redmond, WA) Excel 2010. Bland–Altman
plots were done with MedCalc version 12.5.0.0 software (MedCalc
Software, Ostend, Belgium).
Define thresholds. Thresholds for moderate- and vigorous-intensity
activities have been defined for the ActiGraph14: moderate, 2,690–
6,166 counts (3.0–6.0 metabolic equivalents of task [METs]); and
vigorous, ‡6,167 counts ( >6.0 METs). The activity categories of the
ActiGraph were used as a standard to define the thresholds for the
activity categories of the MOX. To this end, agreement of allocating
activities to either of these categories for the two devices was tested by
making small incremental steps in the MOX thresholds (i.e., 10 MOX
counts) until the smallest absolute difference was obtained between
minutes spent per category between the two devices.
Concurrent validity. For the treadmill measurements Pearson cor-
relation per person was calculated between speed and MOX counts per
minute and between ActiGraph and MOX counts per minute. To ac-
count for the dependency of measurements of speed within partici-
pants, the associations between MOX counts and speed (dependent
variable) and between MOX counts and ActiGraph counts per minute
(dependent variable) were analyzed using multilevel, linear, mixed
model analyses with speed at level 1 and participant at level 2 factors.
Akaike’s information criterion was used to choose the best model. For
daily living measurements the Spearman correlation was calculated
between the counts per minute of the Actigraph and the MOX per
person per day. Values over 0.8 were rated as good. To prevent an
inflated high correlation between the devices due to non-wear time
during daily life measurements, periods of non-wear time were omitted
based on diary information from the participants. Agreement between
minutes per category (moderate- and vigorous-intensity activities)
measured by the different devices was analyzed using Bland–Altman
plots for repeated measures. The mean values and difference with the
ActiGraph were plotted, and the systematic bias and limits of agree-
ment (within mean– 2 standard deviation [SD] of the mean differences)
were obtained. To gain further insight into misclassified minutes,




The first group of five healthy participants had a mean age of
33.4 – 11.6 years. The mean height and weight were 181.0 – 10.1 cm
and 75.7 – 12.3 kg, respectively. The participants wore the devices on
6.8 – 0.8 days.
PARTICIPANTS’ CHARACTERISTICS VALIDATION
Participants’ characteristics are presented in Table 1.
Treadmill. Eight healthy participants, five people with COPD, and
five people with diabetes type 2 walked on the treadmill. The data of 1
patient with COPD could not be used because this person was not able
to walk on the treadmill for 3 min without resting.
Daily living. The 10 healthy participants spent on average 26.1 (SD
18.0) min in the moderate category and 4.4 (SD 13.2) min in the vig-
orous category, as determined by the ActiGraph. Out of 67 days, the
ActiGraph did not record data on 7 days, and on 2 days the battery of
the MOX was empty. Among the participants with a chronic disease,
Table 1. Participants’ Characteristics
HEALTHY PATIENTS
Treadmill (n) 8 9
Age (years) 24.1 (5.3) 60.9 (7.1)
COPD/DM2 (n) — 4/5
Height (cm) 183.3 (9.4) 170.9 (11.4)
Weight (kg) 75.1 (13.4) 92.4 (27.0)
BMI (kg/m2) 22.2 (2.5) 31.3 (7.5)
FEV1 (% predicted) — 52.5 (16.6) (n = 4)
HbA1c (mmol/mol) — 52.2 (6.0) (n = 5)
Daily living (n) 10 12
Age (years) 30.4 (8.3) 61.6 (9.2)
COPD/DM2 (n) — 5/7
Height (cm) 175 (9.6) 168.6 (9.9)
Weight (kg) 68.1 (8.9) (n = 9) 95.6 (31.5)
BMI (kg/m2) 22.7 (2.8) 33.3 (9.8)
Valid wear days 5.8 (1.2) 6.3 (1.4)
Wear time (min/day) 746.4 (191.3) 854.0 (174.6)
FEV1 (% predicted) — 50.5 (12.6) (n = 4)
HbA1c (mmol/mol) — 53.1 (6.4) (n = 7)
BMI, body mass index; COPD, chronic obstructive pulmonary disease; DM2,
diabetes mellitus type 2; FEV1, forced expiratory volume in 1 s; HbA1c,
glycosylated hemoglobin.
VALIDATION OF THE MOX, THE IT’S LIFE! ACTIVITY MONITOR




















































five participants had type 2 diabe-
tes, and seven suffered from COPD.
Patients were active for 11.6 (SD
13.1) min in the moderate category
and 0.7 (SD 3.9) min in the vigorous
category. In chronic disease patients
the ActiGraph did not record data
on 14 out of 89 days.
DEFINE THRESHOLDS
The best possible agreement be-
tween the activity classification of
the ActiGraph and the MOX was
reached with the following thresh-
olds for the MOX: moderate, 400–
860 counts/min; vigorous, 860–N
counts/min. These thresholds were
used to define the minutes of activity
in thedifferent intensity levels during
the daily living of the patients.
CONCURRENT VALIDITY
Treadmill. MOX activity counts
per minute increased with the intensity of walking in healthy par-
ticipants (mean r = 0.98; range, 0.96–0.99) and in patients (mean
r = 0.99; range, 0.98–1). Linear mixed model analyses showed that
MOX counts significantly increased with speed in healthy partici-
pants and in patients (both p < 0.00) (Figs. 2 and 3). Pearson
correlation between the ActiGraph
and the MOX counts per minute
was good. In healthy participants
mean r was 0.99 (range, 0.98–
1.00). In chronic disease patients,
mean r was 0.98 (range, 0.95–
1.00). Linear mixed model analyses
showed that in healthy participants
and in chronic disease patients,
MOX counts significantly increa-
sed with ActiGraph counts (in both
groups, p < 0.00). Figures 2 and 3
show that the threshold for mod-
erate-intensity activities lies be-
tween 3 and 4 km/h and that the
variance in counts increases with
speed. The increase in variance
with speed is also observed in
ActiGraph counts.
Daily living. Spearman corre-
lation per day per participant
between MOX and ActiGraph
counts during daily living was for
healthy participants on average r = 0.72 (range, 0.18–0.96) and in
patients r = 0.82 (range, 0.60–0.94).
In healthy participants, Bland–Altman plots (Figs. 4 and 5) showed
a mean difference of 9.1 min in the moderate category and 1.8 min in
the vigorous category. The 95% limits of agreement were wide: -37.0
Fig. 2. Activity counts per minute of the MOX in healthy participants (hp) during treadmill walking.
Fig. 3. Activity counts per minute of the MOX in chronic disease patients (p) during treadmill walking.
VAN DER WEEGEN ET AL.




















































to 18.8 min in the moderate category and -10.6 to 7.1 min in the
vigorous category.
In the chronic disease patient group, Bland–Altman plots (Figs.
6 and 7) showed a mean difference of 2.3 min/day in the moderate
category between the MOX and the ActiGraph. The limits of
agreement were from - 27.6 to 22.9 min. In the vigorous
category limits of agreement ranged from - 9.5 to 8.5 min
(mean difference, 0.5 min). Within participants there is
a consistent over- or underestimation of minutes per
category.
In healthy participants the MOX placed 3.6% of the total
minutes in a different category, compared with the Acti-
Graph; in chronic disease patients this value was 1.5%.
Histograms of counts of the dissimilar classified minutes
(Figs. 8 and 9) showed that misclassification occurred es-
pecially around category thresholds.
Discussion
In this study thresholds for moderate- and vigorous-
intensity physical activity were defined for the MOX (the
activity monitor embedded in the It’s LiFe! tool), and the
activity results from the MOX were compared with the ac-
tivity results from the ActiGraph GT3X to assess concurrent
validity.
MOX activity counts per minute did significantly increase
with speed and had an excellent correlation with the refer-
ence activity monitor, the ActiGraph GT3X, on the treadmill
(mean r = 0.99 and 0.98, respectively) and a moderate to
good correlation in daily living (mean r = 0.72 and 0.82,
respectively). Bland–Altman plots showed that during daily living
there was no perfect agreement between the number of minutes the
MOX and the ActiGraph placed in the moderate- and vigorous-
intensity activity categories. Sometimes, the MOX overestimated
activity compared with the ActiGraph, and sometimes the MOX
underestimated activity, with an average overestimation in
both categories. In total, the MOX misclassified 3.6% of the
total analyzed minutes of healthy participants and 1.5% of
the minutes for chronic disease patients. With the chosen
design it is not known, however, whether the ActiGraph or
the MOX is responsible for the misclassification. The Acti-
Graph GT3X does not have a perfect correlation (r = 0.68)
with measures of energy expenditure, DLW,17 or indirect
calorimetry (r = 0.77).16 In addition, in this study the Acti-
Graph did not work on 21 days out of 156 days (these days
were excluded from the analyses), and sometimes there were
suspicious data (i.e., long periods of zero ActiGraph counts
were observed on 7 days [included in the analyses]). A check
of the analyses without these days resulted in minimal
changes. Most important, however, was that misclassifica-
tion did occur around category thresholds, which shows that
misclassification is inevitable with the choice of hard
thresholds.
A potential alternative for hard thresholds is ‘‘fuzzy logic
sets.’’ With the fuzzy logic classifier a count will not be
classified in one activity category, but it will represent how
much it corresponds to each category. At that moment if–
then rules will be applied to classify the count to an activity
category.20
Fig. 4. Determination of agreement between the ActiGraph accelerometer
and MOX in minutes in the moderate-intensity category for healthy participants
by Bland–Altman plots for repeated measures. The solid line represents the
mean difference between the devices; the dashed lines represent the limits of
agreement. SD, standard deviation.
Fig. 5. Determination of agreement between the ActiGraph accelerometer
and MOX in minutes in the vigorous-intensity category for healthy participants
by Bland–Altman plots for repeated measures. The solid line represents the
mean difference between the devices; the dashed lines represent the limits of
agreement. SD, standard deviation.
VALIDATION OF THE MOX, THE IT’S LIFE! ACTIVITY MONITOR




















































Another issue with hard thresholds is that at-the-same-speed
counts differ between participants, and variance between partici-
pants increased with speed. Therefore there is a difference in the
prediction equation if running is included (in healthy participants).
Another study also proved that the slope of prediction equations
differs among different activities.21 Also, in other studies the
variance of the counts increased with speed,22–24 and even
the variance in volume of O2 (in mL/kg/min) increased with
speed.25,26 However, within participants MOX counts in-
creased consistently, and during daily life there was a merely
consistent over- or underestimation of activity per partici-
pant. The difference in counts per participant could be caused
by a different walking pattern, body composition, or a
slightly different placement of the device. For instance, a
small person with a higher step frequency than a taller person
will collect more counts per minute. Therefore it is hard to set
one threshold for all users. For an equation to calculate
personal thresholds at 3 METs, based on weight, height, and
age, the MOX should be validated with DLW or indirect
calorimetry.
However, a different threshold per user is undesirable in
daily practice and does not guarantee a perfect fit between
threshold and user. In a recent study by Santos-Lozano
et al.,27 new equations were formulated to predict energy
expenditure from activity counts, age, body mass, and
gender in different age groups. With the new equations,
more accurate thresholds were defined. Yet, significant
differences between energy expenditure calculated from the
equations and indirect calorimetry were still observed at
certain speeds. In daily living differences between energy expen-
diture measured by accelerometer output and indirect calorimetry
will be even higher because accelerometers worn on the hip are
mostly sensitive to gait-related activities and not for activities in-
volving upper-extremity movement or seated activities.28 Fur-
thermore, people with chronic disorders like COPD have a
poor mechanical efficiency compared with healthy peo-
ple,29 which means that a threshold set at 3 METs for the
general population is not achievable for people with COPD.
Consequently results of the It’s LiFe! tool will not be a
perfect representation of an individual’s physical activity.
In a previous study,30 accelerometer output resulted in a
16.4% difference with direct observation of energy ex-
penditure. Future research could refine MOX thresholds,
with a validation study with indirect calorimetry. Also, the
thresholds in this study were defined while the MOX and
the ActiGraph were placed on the lower back, when in re-
ality they will be worn on the hip, and ActiGraph thresholds
were defined for wearing on the hip.
In the It’s LiFe! Intervention, the uncertainties caused by
the rigid thresholds are solved by a premeasurement period.
Participants of the intervention use the tool for 2 weeks, and
after this interval they set a personal goal in collaboration
with their care provider. Thus individual factors that influ-
ence activity outcome are taken into account, and personal
progress is measured after goal setting. Furthermore, care
providers are instructed to lower the threshold (270 counts/
min for – 2 km/h, 363 counts/min for – 3 km/h) in case the
premeasurement reveals that a participant is unable to
Fig. 6. Determination of agreement between the ActiGraph accelerometer
and MOX in minutes in the moderate-intensity category for chronic disease
patients by Bland–Altman plots for repeated measures. The solid blue line
represents the mean difference between the devices; the dashed lines
represent the limits of agreement. SD, standard deviation.
Fig. 7. Determination of agreement between the ActiGraph accelerometer
and MOX in minutes in the vigorous-intensity category for chronic disease
patients by Bland–Altman plots for repeated measures. The solid blue line
represents the mean difference between the devices; the dashed lines rep-
resent the limits of agreement. SD, standard deviation.
VAN DER WEEGEN ET AL.




















































exceed the general threshold while walking. This does not overcome
the fact that non–gait-related activities will be underestimated.
Therefore the participants have the opportunity to write down re-
marks in the system to notate extra activities.
In conclusion, the MOX is able to assess differences in activity
intensity and classify free-living physical activity behavior in min-
utes and can be used in the It’s
LiFe! intervention. However, one
should bear in mind the general
limitations of an accelerometer.
One of the strengths of the inter-
vention is that it starts with a
personal premeasurement. To es-
timate energy expenditure with
the MOX, the MOX should be val-
idated with DLW or indirect calo-
rimetry. The effects on physical
activity of the It’s LiFe! tool em-
bedded in primary care practice
will be evaluated in a randomized
controlled trial in 24 general
practices.
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Fig. 9. Histogram of counts of misclassified minutes in chronic disease patients.
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